This year, the FORTH Award for Excellence in Academic Teaching "Vassilis XANTHOPOULOS - Stephanos PNEVMATIKOS" will be presented by H.E. the President of the Hellenic Republic, Ms. Katerina Sakellaropoulou to Mr. Eleftherios Zouros, Emeritus Professor, Dept. of Biology, University of Crete.

Α big European research project on developing new software tools for the accurate prognosis and precise treatment of prostate cancer, will be coordinated by Prof. Manolis Tsiknakis, Affiliated Professor at the Institute of Computer Science (ICS) of FORTH.

As announced today in Brussels, Nektarios Tavernarakis, Chairman of the Board of Directors at the Foundation for Research and Technology – Hellas (FORTH), and Professor at the Medical School of the University of Crete, was unanimously elected Vice President of the European Research Council (ERC).

The European Geoscience Union (EGU) will award Prof. Spyros Pandis the medal Vilhelm Bjerknes for 2021. Prof. Pandis is a collaborating faculty member of FORTH/ICE-HT (Institute of Chemical Engineering Sciences) and professor at the Department of Chemical Engineering of the University of Patras. This medal is awarded for significant disciplinary contributions in the Earth, planetary and space sciences and the ceremony will be held during the EGU Annual Assembly, 25-30 April 2021.

A new spin-off company under the name “Biomimetic” was created leveraging patented technology developed at the Institute of Electronic Structure and Laser (IESL, www.iesl.forth.gr) of the Foundation for Research and Technology-Hellas (www.forth.gr). The company was founded by the Research Director Dr. Emmanuel Stratakis, together with FORTH research personnel Dr. Evangelos Skoulas, Mr. Andreas Lemonis, Mr. Antonis Papadopoulos and Mr. Alexandros Mimidis, as co-founders. The company raised 900.000€ seed funding by Big Pi Ventures (https://bigpi.vc/), one of the funds of EquiFund supported by the European Investment Fund (EIF). It is the second spin-off company of IESL that is financed by Big Pi within the last six months.

Biosensors lab of FORTH(http://biosensorslab.biology.uoc.gr/) has developed a novel molecular diagnostic method for the detection of nucleic acids at the point-of-care. The method exploits a newly designed portable 3D-printed device and a smartphone to perform isothermal amplification and real-time quantitative colorimetric detection of the target analyte. The simplicity of the methodology, rapid analysis time (<30 min) and affordable cost make it ideal for non-trained users at the point-of-need and in both the developed and resource limited countries. Clinical validation of the device with patients’ samples, for infectious diseases (COVID-19) and cancer-mutations (BRAF V600E) detection, demonstrated excellent performance compared to standard methods.